{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:48:32Z","timestamp":1766551712136,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejca.2021.04.037","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T20:51:24Z","timestamp":1623444684000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies"],"prefix":"10.1016","volume":"153","author":[{"given":"Sydney","family":"Ch'ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semra","family":"Uyulmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo S.","family":"Carlino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8538-3132","authenticated-orcid":false,"given":"Kerwin F.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rtshiladze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R.","family":"Stretch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2997-6413","authenticated-orcid":false,"given":"Omgo E.","family":"Nieweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander H.R.","family":"Varey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rony","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Pires da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-5544","authenticated-orcid":false,"given":"Serigne N.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8354-434X","authenticated-orcid":false,"given":"Andrew J.","family":"Spillane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-0013","authenticated-orcid":false,"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8894-3545","authenticated-orcid":false,"given":"Georgina V.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-806X","authenticated-orcid":false,"given":"Robyn P.M.","family":"Saw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-2496","authenticated-orcid":false,"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.04.037_bib1","series-title":"Cutaneous melanoma","first-page":"1359","article-title":"Surgical management of distant melanoma metastases","author":"Thompson","year":"2020"},{"key":"10.1016\/j.ejca.2021.04.037_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/000313481508101019","article-title":"Adrenalectomy for metastatic melanoma: current role in the age of nonsurgical treatments","volume":"81","author":"Flaherty","year":"2015","journal-title":"Am Surg"},{"key":"10.1016\/j.ejca.2021.04.037_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamasurg.2017.0460","article-title":"Metastasectomy for abdominal visceral oligometastatic melanoma","volume":"152","author":"DePeralta","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejca.2021.04.037_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamasurg.2017.0459","article-title":"Association of surgical treatment, systemic therapy, and survival in patients with abdominal visceral melanoma metastases, 1965-2014: relevance of surgical cure in the era of modern systemic therapy","volume":"152","author":"Deutsch","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejca.2021.04.037_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.04.037_bib6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.04.037_bib7","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(20)30417-7","article-title":"Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"395","author":"Zimmer","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2021.04.037_bib8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/01.rlu.0000099805.36471.aa","article-title":"The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making","volume":"28","author":"Gulec","year":"2003","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejca.2021.04.037_bib9","first-page":"176","article-title":"Surgery for distant melanoma metastasis","volume":"18","author":"Leung","year":"2012","journal-title":"Canc J"},{"key":"10.1016\/j.ejca.2021.04.037_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.26111","article-title":"A Phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430","volume":"117","author":"Sosman","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2021.04.037_bib11","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1245\/s10434-017-6072-3","article-title":"Long-term survival after complete surgical resection and adjuvant immunotherapy for distant melanoma metastases","volume":"24","author":"Faries","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2021.04.037_bib12","first-page":"218","article-title":"Survival after surgical resection of isolated pulmonary metastases from malignant melanoma","volume":"13","author":"Andrews","year":"2006","journal-title":"Canc Contr"},{"key":"10.1016\/j.ejca.2021.04.037_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archsurg.1996.01430210073013","article-title":"Surgical resection for melanoma metastatic to the gastrointestinal tract","volume":"131","author":"Ollila","year":"1996","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejca.2021.04.037_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2021.04.037_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2021.04.037_bib16","first-page":"30494","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial","volume":"S1470\u20132045","author":"Ascierto","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.04.037_bib17","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/2159-8290.CD-16-0577","article-title":"Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease","volume":"6","author":"Liu","year":"2016","journal-title":"Canc Discov"},{"key":"10.1016\/j.ejca.2021.04.037_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41591-020-01188-3","article-title":"Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)","volume":"27","author":"Menzies","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2021.04.037_bib19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3171\/2010.5.JNS1014","article-title":"Outcome predictors of gamma knife surgery for melanoma brain metastases","volume":"114","author":"Liew","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2021.04.037_bib20","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"article-title":"Skin surgery: prevention and treatment of complications","year":"2020","author":"Ritchie","key":"10.1016\/j.ejca.2021.04.037_bib21"},{"key":"10.1016\/j.ejca.2021.04.037_bib22","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.04.037_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtcvs.2009.08.026","article-title":"Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database","volume":"139","author":"Paul","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2021.04.037_bib24","doi-asserted-by":"crossref","first-page":"211s","DOI":"10.1016\/S0753-3322(00)80047-5","article-title":"Complications of laparoscopic and retroperitoneoscopic adrenalectomies in 370 cases in Japan: a multi-institutional study","volume":"54","author":"Terachi","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejca.2021.04.037_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2018.12.012","article-title":"Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients","volume":"108","author":"Ben-Betzalel","year":"2019","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.04.037_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jgo.2017.04.003","article-title":"Checkpoint Inhibition and melanoma: considerations in treating the older adul","volume":"8","author":"Friedman","year":"2017","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.ejca.2021.04.037_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/annonc\/mdw443","article-title":"Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab","volume":"28","author":"Menzies","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.04.037_bib28","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jaad.2019.07.005","article-title":"Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review","volume":"82","author":"Fisher","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2021.04.037_bib29","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1158\/1078-0432.CCR-17-2386","article-title":"Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab","volume":"24","author":"Joseph","year":"2018","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejca.2021.04.037_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.32522","article-title":"Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti\u2013PD-1 therapy","volume":"126","author":"Pires da Silva","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2021.04.037_bib31","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3390\/cancers12051176","article-title":"Surgery for unresectable stage IIIC and IV melanoma in the era of new systemic therapy","volume":"12","author":"Blankenstein","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2021.04.037_bib32","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1245\/s10434-019-08099-9","article-title":"Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade","volume":"27","author":"Bello","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2021.04.037_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2018.08.008","article-title":"The impact of effective systemic therapies on surgery for stage IV melanoma","volume":"103","author":"Smith","year":"2018","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.04.037_bib34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archsurg.136.8.950","article-title":"Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney melanoma unit experience","volume":"136","author":"Rose","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejca.2021.04.037_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/SLA.0000000000002749","article-title":"Adrenal metastasectomy in the presence and absence of extraadrenal metastatic disease","volume":"270","author":"Russo","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2021.04.037_bib36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921002896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921002896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:31:37Z","timestamp":1760733097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921002896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":36,"alternative-id":["S0959804921002896"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.04.037","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}